✦ LIBER ✦

Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia

✍ Scribed by Kitagawa, M; Yamaguchi, S; Takahashi, M; Tanizawa, T; Hirokawa, K; Kamiyama, R

Book ID: 110053809
Publisher: Nature Publishing Group
Year: 1998
Tongue: English
Weight: 630 KB
Volume: 12
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2400980

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Selective involvement of the Fas (CD95)

Selective involvement of the Fas (CD95) / Fas ligand pathway in bone marrow B cell progenitors

✍ Yasmina Laouar; Florence Vasseur; Géraldine Moreau; Corinne Garcia; Valérie Pasq 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 2 views

Expression of Fas and Fas ligand in cuta

Expression of Fas and Fas ligand in cutaneous B-cell lymphomas

✍ Zoi-Toli, Ourania; Meijer, Chris J. L. M.; Oudejans, Joost J.; de Vries, Els; va 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 3 views

Primary cutaneous B-cell lymphomas (CBCLs) represent a rare, but distinct group of B-cell neoplasms with a different clinical behaviour to B-cell lymphomas secondarily involving the skin. Fas-Fas ligand (Fasl) expression was investigated in a group of primary and secondary CBCLs to gain an insight i

Expression of Fas and Fas ligand in huma

Expression of Fas and Fas ligand in human testicular germ cell tumours

✍ E. Baldini; S. Ulisse; E. Marchioni; A. Di Benedetto; G. Giovannetti; E. Petrang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

The distribution and intracellular locat

The distribution and intracellular location of Fas and Fas Ligand following gastric carcinogenesis: Fas Ligand expressing gastric carcinoma cells can inhibit local immune response

✍ Huanran Liu; Hideyuki Ubukata; Takanobu Tabuchi; Takeshi Nakachi; Hiroyuki Nagat 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 355 KB

Fas/Fas ligand-mediated elimination of a

Fas/Fas ligand-mediated elimination of antigen-bearing Langerhans cells in draining lymph nodes

✍ Kawamura; Azuma; Kayagaki; Shimada; Yagita; Okumura 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

Fas and Fas ligand expression in tumor c

Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas

✍ Lucie Peduto Eberl; Louis Guillou; Emilia Saraga; Michael Schröter; Lars E. Fren 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 906 KB

CD95/APO-1 ligand (FasL) is implicated in the maintenance of immune privileged sites by inducing apoptosis of activated infiltrating T lymphocytes. Therefore, progressive tumors might express high levels of FasL and develop as immune privileged sites. In this study, we investigated the expression of